0001989478-24-000001.txt : 20240904 0001989478-24-000001.hdr.sgml : 20240904 20240904125236 ACCESSION NUMBER: 0001989478-24-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240904 DATE AS OF CHANGE: 20240904 EFFECTIVENESS DATE: 20240904 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Superluminal Medicines, Inc. CENTRAL INDEX KEY: 0001989478 ORGANIZATION NAME: IRS NUMBER: 883006168 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-523131 FILM NUMBER: 241276583 BUSINESS ADDRESS: STREET 1: 200 BERKELEY ST., 18TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: (301) 525-8752 MAIL ADDRESS: STREET 1: 200 BERKELEY ST., 18TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 D 1 primary_doc.xml X0708 D LIVE 0001989478 Superluminal Medicines, Inc. 303 WYMAN ST. SUITE 300 WALTHAM MA MASSACHUSETTS 02451 (301) 525-8752 DELAWARE Superluminal Medicines, LLC None Corporation true 2023 CONY D'CRUZ c/o SUPERLUMINAL MEDICINES 303 WYMAN ST., SUITE 300 WALTHAM MA MASSACHUSETTS 02451 Executive Officer Director Promoter ANDREW LEVIN c/o SUPERLUMINAL MEDICINES 303 WYMAN ST., SUITE 300 WALTHAM MA MASSACHUSETTS 02451 Director DYLAN MORRIS c/o SUPERLUMINAL MEDICINES 303 WYMAN ST., SUITE 300 WALTHAM MA MASSACHUSETTS 02451 Director CATHERINE RIESEN c/o SUPERLUMINAL MEDICINES 303 WYMAN ST., SUITE 300 WALTHAM MA MASSACHUSETTS 02451 Executive Officer DIAMANTIS XYLAS c/o SUPERLUMINAL MEDICINES 303 WYMAN ST., SUITE 300 WALTHAM MA MASSACHUSETTS 02451 Director Biotechnology Decline to Disclose 06b false 2024-08-21 true true false 0 119999984 20041660 99958324 false 12 0 0 0 false Superluminal Medicines, Inc. /s/ Cony DCruz Cony DCruz Chief Executive Officer 2024-09-04